The approval is based on the pivotal TRIDENT-1 trial, in which Augtyro successfully achieved a high objective response rate and durable response1
Augtyro adds to Bristol Myers Squibb’s growing.
An observational research of more than 329,000 Medicare admissions discovered that the quality and cost of care for older patients receiving hospital care from
Unexpected weight loss and a sudden change in bowel habits could be signs of danger. People should pay attention to these bowel cancer early warning signs and symptoms